Plasma p-tau217: biomarker evidence

Plasma p-tau217 appears in 1 entry of the OSMF biomarker atlas, covering Alzheimer's Disease and Other Dementias. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Alzheimer's Disease and Other Dementias

Where Plasma p-tau217 is reported

ConditionDirectionCompared againstAssociated symptomsSource
Alzheimer's Disease and Other Dementias↑ elevatedPSEN1 E280A mutation non-carriersnot specifiedMalotaux et al. 2025

Frequently asked questions

In which conditions is Plasma p-tau217 altered?

In the OSMF atlas Plasma p-tau217 is reported in Alzheimer's Disease and Other Dementias. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Plasma p-tau217?

The atlas entries for Plasma p-tau217 do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Plasma p-tau217 result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Plasma p-tau217 across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/markers/plasma-p-tau217.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.